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Spinocerebellar ataxia type 7 (SCA7) is an autosomal 
dominant neurodegenerative disorder caused by an unsta-
ble CAG repeat in the coding region of ataxin-7 gene1. A 
wide variety of neurological manifestations have been de-
scribed in these patients, including ataxic gait, visual loss, 
dysartria, nystagmus, ophthalmoplegia, dysphagia, dysto-
nia, and pyramidal and extrapyramidal signs2. 
Different combinations of these manifestations may 
be found in individual patients, either among as within 
families3, but the commonly described onset clinical man-
ifestations are cerebellar ataxia and visual impairment4,5. 
We report a molecular proven SCA7 patient whose ini-
tial manifestation was spastic paraparesis in the absence 
of any definite cerebellar or visual impairment at the ini-
tial phases of the disease. 
METHOD
We have retrospectively analyzed the onset manifestations 
of all SCA7 patients whose molecular diagnosis was confirmed 
at the DNA Laboratory of The Department of Neurology of the 
School of Medicine of Ribeirão Preto, University of São Pau-
lo. The affected members and their families were reevaluated 
by one of us (SL). This study was approved by the Research Eth-
ics Committee of our hospital and all participants gave an writ-
ten informed consent. The SCA7 expansion was tested as de-
scribed in Linhares6. 
RESuLTS
We have found 44 SCA7 patients, from 3 different fam-
ilies. The most frequent onset manifestation was cerebel-
lar ataxia, present in 23 patients, followed by visual loss, 
the initial complaint of other 20 patients. The last affect-
ed individual presented an unusual manifestation: spas-
tic paraparesis. This patient, individual VI.12 on the pre-
sented family tree (Figure), was a 50-year-old man when 
first seen at our institution. He complained that his legs 
seemed to be stiff since his twenties but at the age of 43 
years this stiffness progressively increased, impairing his 
walking abilities. He denied any other neurological mani-
festation, including sphincter or sexual dysfunction, visu-
al abnormalities or loss of balance. On neurological ex-
amination, at age of 50, sensation was normal, but his gait 
was clearly spastic and tonus was significantly increased 
in the lower limbs, where a mild pyramidal weakness was 
also detected. No atrophy or abnormal movement was 
observed. His tendon jerks were hyperreflexic in the low-
er limbs, increased in the upper limbs, and the plantar re-
sponses were extensor bilaterally. His jaw reflex was also 
Figure. Brazilian family with spinocerebellar ataxia type 7: ◦=unffect-
ed female; □=unffected male; ●=affected female; ■=affected male; 
◇=unffected male or female. The numbers inside  the brackets  in-
dicate  the size of the CAG repeats in each allele. The diagonal line 
across a symbol indicates a deceased individual. The arrow indicates 
the proband.
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mildly increased. Contrasting to the exuberance of the 
pyramidal signs, on the finger-nose test there was a very 
mild decomposition and his ocular movements were also 
very mildly hypermetric, although saccades were pre-
served. No other abnormality was detected, including vi-
sion, hearing, pupilar reflexes, speech, memory and intel-
lectual functions. At this time he was clinically diagnosed 
as having a spastic paraparesis syndrome, most probably 
a pure HSP. On evaluation of his family, however, it was 
noted that one of his aunts, individual V-2, 72 years old, 
was healthy until the age of 42 years when she first no-
ticed a progressive visual loss. On examination, she was 
wheelchair bound, her speech was slurred and there was 
an evident limb dysmetria. The proband’s brother (VI-2), 
58 years, reported an 18-years history of unsteady gait 
and 10 years of bilateral progressive visual failure. At the 
examination, he was also wheelchair bound, presented a 
slurred speech and an exacerbated limb dysmetria. His sis-
ter (VI-5), 53 years, was also committed by loss of balance 
since she was 43 years old, and on examination we noted 
gait ataxia, limb dysmetria, dysartria and a moderate vi-
sual loss. Six affected individuals, including the probands 
father died before our evaluation, but it seems that in all 
of them the disease started with an ataxic gait. Laborato-
ry investigation of the proband was normal to HTLV I and 
II, VDRL, FTA-abs (in serum and CSF), autoantibodies and 
CSF examination. A spinal cord MRI revealed only a mild 
disc protrusion at C4-C5 and C5-C6 levels, without spi-
nal cord compression. A neurophysiologic screening for 
peripheral neuropathy was also normal. Based mainly on 
his family evaluation than in his own clinical manifesta-
tions, he was also submitted to a brain MRI that revealed 
a moderate atrophy of the cerebellar hemispheres. Af-
ter informed consent, he and his available affected family 
members were tested to the SCA7 CAG expansion, due to 
the association of spinocerebellar manifestations and vi-
sual loss that turned out to be positive in all of them. The 
expansion sizes are depicted in brackets in Figure.
 
DISCuSSION
Involvement of the corticospinal tract is a common 
feature among of the autosomal dominant cerebellar 
ataxias, although a spastic gait has rarely been reported 
as an isolated onset manifestation. Sakai and Kawakami7 
first described two siblings presenting spastic paraparesis 
in the early years of their disease that later developed 
the characteristic manifestations of the spinocerebel-
lar ataxias. Since then other patients with similar clinical 
features have been described, respectively, by Kaneko8 
and Teive9. All these patients were diagnosed as having 
SCA3/MJD disease. Previously, Sequeiros and Coutinho10 
had observed that many patients at risk for Machado-Jo-
seph disease (MJD) presented hyperreflexia on neurologi-
cal examination, and that the first manifestation of the 
patients they studied resulted from pyramidal as well as 
cerebellar dysfunctions. Based on his own observations 
and those of Sequeiros and Coutinho, Sakai and Kawakami 
proposed that spastic paraplegia might be an SCA3/MJD 
under recognized onset manifestation. To the best of 
our knowledge no patient with SCA7 presenting isolated 
spastic paraparesis as the initial manifestation has been 
described so far and hyperreflexia does not seem to be 
a recognized abnormality in at risk individuals with this 
type of spinocerebellar degeneration2,11.
The normal range of the CAG repeats described in 
SCA7 disease ranges from 7 to 35, and the lowest patho-
logical number of repeats was established to be 375. Jo-
hansson11 verified that those patients presenting with visu-
al impairment have a higher number of CAG repeats (>59) 
while those beginning with ataxia have a lower number 
of repeats (<59). In the Brazilian family we are reporting, 
all affected members had a low number of CAG repeats, 
ranging from 38 to 43, although their onset manifesta-
tion varied among cerebellar ataxia, visual loss and spastic 
paraparesis. The observations made in this family show 
significant intra-familial phenotypic variability but do not 
reflect the influence of the number of the trinucleotide 
repeats in the nature of the initial symptom, as has been 
previously stated.
Instead of being diagnosed as having a spinocerebel-
lar ataxia syndrome at the initial stages of his disease, 
the proband we describe was diagnosed as having an 
hereditary spastic paraparesis, a group of inherited dis-
orders in which the main features are progressive gait 
disturbance, spasticity of the lower limbs, hiperreflexia, 
extensor plantar responses and a disproportionate mild 
pyramidal weakness12. Harding13 classified the HSP in two 
large groups, nominated as pure and complicated HSPs. In 
“pure” HSP the clinical manifestation are entirely domi-
nated by the upper motor neuron syndrome, although mi-
nor abnormalities in cerebellar or sensory functions are 
admitted; while in “complicated” HSP many other systems 
may be involved in addition to spasticity, including optic 
atrophy, retinopathy, extrapyramidal disease, amyotrophy, 
dementia, ataxia, mental retardation, deafness, icthyosis, 
peripheral neuropathy and epilepsy. As is the case to 
SCA39, most patients with SCA7 must be differentiated 
from “complicated” HSP in the course of their disease, 
as both diseases show common manifestations, including 
ataxia, spasticity, retinopathy and extrapyramidal signs13. 
Occasionally, this distinction may be dificult in the course 
of the disease due to the absence of a clear predominance 
of the spasticity or of the cerebellar manifestations. The 
case we present, however, implies in a new clinical situ-
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ation. As has already been recognized to SCA37,8, SCA7 
should also now be considered in the differential diagno-
sis of patients presenting with “pure” HSP. As this pheno-
type does not seem to run in all affected family members, 
evaluation of other affected sibs may direct to the diag-
nosis of SCA7 if there are members with visual impair-
ment, or to both SCA7 and SCA3 if the affected members 
present a classic spinocerebellar syndrome. 
In conclusion, it has already been recognized that 
clinical overlap between “complicated” forms of HSP and 
SCA3 and SCA7 should always be considered in the diag-
nosis process, but to this already known possibility we 
add the fact that SCA7 may also present syndromically as 
a “pure” HSP, and unless there are other diagnostic clues, 
mostly information from other affected members of the 
family, we think that all patients with the phenotype of 
spastic paraparesis should also be submitted to the DNA 
test for SCA7. This observation broadens the differential 
diagnosis of HSP, as also the neurological manifestations 
that can herald SCA7 disease, in addition to the classi-
cally recognized cerebellar ataxia and visual loss mani-
festations. 
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